Will Celldex Therapeutics (CLDX) Report Negative Q3 Earnings? What You Should Know
The market expects Celldex Therapeutics (CLDX) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook is important in assessing the ... [Read]
What’s in Store for Selecta (SELB) This Earnings Season?
We expect investors to focus on Selecta Biosciences, Inc. ’s SELB progress with its lead pipeline candidate SEL-212 and its recent licensing agreements for other pipeline developments during the third-quarter 2020 earnings call. The company’s ... [Read]
Avenue Therapeutics’ Pain Drug Gets Complete Response Letter
Avenue Therapeutics, Inc. ATXI announced that the FDA has issued a complete response letter (CRL) to its new drug application (NDA), through which it is seeking approval for its pipeline candidate intravenous (IV) tramadol. The ... [Read]
Compass Pathways’ Historic IPO Shines Spotlight on Alternative Mental Health Treatments
October 7, 2020 (MicroSmallCap via Comtex) — Depression, anxiety, post-traumatic stress disorder (PTSD), and other mental illnesses have been prevalent in the US for quite some time, but the coronavirus pandemic has triggered a full-blown ... [Read]
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming® System
– Project Focused on Proteins used in the Production of Blood Cells – NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract ... [Read]
Compass Pathways Leads the Way as the First Psychedelics Company to IPO on the Nasdaq
September 24, 2020 (MicroSmallCap via Comtex) — Last year may have been all about cannabis, but it’s clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since Johnson & Johnson’s (NYSE:JNJ) ketamine-derived ... [Read]
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
LAVAL, Québec, Sept. 11, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has filed and mailed the information circular and management proxy statement (the ... [Read]
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
Innovative Products Designed to Meet Needs of Surgeons and their Patients in Joint Preservation and Restoration Procedures BEDFORD, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, ... [Read]
4 Biotech Penny Stocks Up Big in April: Will the Gains Continue?
Biotech penny stocks are biotech stocks that sell for less than $5 per share. Most early-stage clinical biotech companies usually fall into the penny stock range. They are prone to market volatility and have large ... [Read]
4 Low Float Biotech Stocks to Buy in April
In the wake of the coronavirus pandemic, biotech stocks have been of interest to investors, given that they’re some of the top gainers in the past few weeks. In particular, low float biotech stocks have ... [Read]